Menu
Menu
BridgeBio is on a mission to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases, and is dedicated to serving these individuals, their families, and the communities they are part of through education, empathy, and awareness. [continue reading]
BBP-812 Gene Therapy Program for Canavan Disease
NTSAD - 46th Annual Family Conference
BBP-812 Gene Therapy Program for Canavan Disease
NTSAD - 45th Annual Family Conference
CANinform Natural History Study Design and COVID-19 Mitigation
The Joint 16th ICNA Congress & 49th Annual CNS Meeting
Natural History Study Design - Charlotte, NC
48th Annual Meeting of the Child Neurology Society
IV administration compared to IT and ICV - Barcelona, Spain
European Society for Gene & Cell Therapy
Natural History Study Design - Munich, Germany
Congress for Pediatrics and Adolescent Medicine, focused on pediatric neurology
Building a Natural History Study for Canavan Disease Washington, D.C.
EveryLife Foundation Annual Scientific Workshop
CANaspire Family Brochure
CANinform Family Brochure
Information and support are available for families affected by Canavan disease from advocacy organizations such as:
Families can also access resources on gene therapy, drug development and understanding clinical trials by visiting:
